title: Gene Mutation Profiling of Breast Cancers for Clinical Decision Making: Drivers and Passengers in the Cart Before the Horse.
authors.affiliation: Breast and Ovarian Cancer Program, Johns Hopkins School of Medicine, Baltimore, Maryland2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
authors.forename: Vered
authors.initials: V
authors.lastname: Stearns
authors.affiliation: Breast and Ovarian Cancer Program, Johns Hopkins School of Medicine, Baltimore, Maryland2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
authors.forename: Ben Ho
authors.initials: BH
authors.lastname: Park
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D001706:Biopsy; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D058534:Class I Phosphatidylinositol 3-Kinases; D004252:DNA Mutational Analysis / Q000639:trends; D004059:Diffusion of Innovation; D005260:Female; D020869:Gene Expression Profiling / Q000639:trends; D020022:Genetic Predisposition to Disease; D006801:Humans; D058990:Molecular Targeted Therapy; D009154:Mutation; D010641:Phenotype; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D057285:Precision Medicine / Q000639:trends; D011237:Predictive Value of Tests; D015203:Reproducibility of Results
chemical_list: D014408:Biomarkers, Tumor; D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human